Table 1 HLA-A allele frequency in patients with ESRD and controls.
From: Associations between end stage renal disease and HLA polymorphisms in the Guangxi Zhuang population
ESRD (2n = 650) | Control (2n = 700) | P | Pc | OR | 95% CI | |||
|---|---|---|---|---|---|---|---|---|
NO. | AF (%) | NO. | AF (%) | |||||
11:01 | 221 | 34.00 | 200 | 28.57 | 0.031 | NS | 1.288 | 1.023–1.622 |
24:02 | 92 | 14.15 | 117 | 16.71 | 0.194 | NS | 0.822 | 0.611–1.105 |
02:03 | 83 | 12.77 | 111 | 15.86 | 0.106 | NS | 0.777 | 0.571–1.056 |
02:07 | 77 | 11.85 | 75 | 10.71 | 0.511 | NS | 1.120 | 0.799–1.570 |
33:03 | 55 | 8.46 | 60 | 8.57 | 0.942 | NS | 0.986 | 0.673–1.445 |
11:02 | 30 | 4.62 | 42 | 6.00 | 0.258 | NS | 0.758 | 0.469–1.227 |
02:01 | 25 | 3.85 | 19 | 2.71 | 0.242 | NS | 1.434 | 0.782–2.629 |
02:06 | 17 | 2.62 | 19 | 2.71 | 0.910 | NS | 0.963 | 0.496–1.868 |
26:01 | 15 | 2.31 | 16 | 2.29 | 0.979 | NS | 1.010 | 0.495–2.059 |
29:01 | 7 | 1.08 | 14 | 2.00 | 0.171 | NS | 0.533 | 0.214–1.330 |
30:01 | 7 | 1.08 | 4 | 0.57 | 0.302 | NS | 1.894 | 0.552–6.501 |
03:01 | 6 | 0.92 | 7 | 1.00 | 0.885 | NS | 0.922 | 0.308–2.759 |
31:01 | 5 | 0.77 | 2 | 0.29 | 0.272 | NS | 2.705 | 0.523–13.993 |
24:03 | 3 | 0.46 | 1 | 0.14 | 0.357 | NS | 3.241 | 0.336–31.237 |
01:01 | 1 | 0.15 | 5 | 0.71 | 0.220 | NS | 0.214 | 0.025–1.838 |
23:01 | 1 | 0.15 | 0 | 0 | ||||
24:01 | 1 | 0.15 | 0 | 0 | ||||
24:07 | 1 | 0.15 | 0 | 0 | ||||
68:01 | 1 | 0.15 | 0 | 0 | ||||
74:01 | 1 | 0.15 | 3 | 0.43 | 0.625 | NS | 0.358 | 0.037–3.450 |
74:02 | 1 | 0.15 | 0 | 0 | ||||
